Skip to main content
STRIDES PHARMA SCIENCE LIMITED logo

STRIDES PHARMA SCIENCE LIMITED — Investor Relations & Filings

Ticker · STAR ISIN · INE939A01011 LEI · 335800WHFYXUCHR9DD10 BSE.NS Manufacturing
Open in API
Filings indexed 1,200 across all filing types
Latest filing 2022-07-14 Regulatory Filings
Country IN India
Listing BSE.NS STAR

About STRIDES PHARMA SCIENCE LIMITED

https://www.strides.com

Strides Pharma Science Limited is a global pharmaceutical organization focused on the development and manufacture of IP-led niche finished dosage formulations. The company’s product portfolio encompasses a wide range of therapeutic areas, specializing in complex oral solids, softgel capsules, topicals, and liquids. It maintains a significant presence in highly regulated markets, including the United States, Europe, and Australia, while also serving institutional and emerging markets. The company operates multiple manufacturing facilities globally, many of which are approved by major international regulatory agencies such as the USFDA. Strides emphasizes research and development to drive innovation in specialized delivery systems and difficult-to-manufacture products, positioning itself as a key player in the global generic pharmaceutical landscape.

Recent filings

Filing Released Lang Actions
Loss of share certificate
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges regarding a shareholder's request for issuance of a duplicate share certificate. It references compliance with SEBI regulations and includes correspondence between the company, registrar, and shareholder. The content is about a procedural update on share certificate issuance, not a financial report, earnings release, or management discussion. It does not contain financial data or results, nor is it a report publication announcement. The document fits best under Regulatory Filings (RNS) as it is a regulatory compliance communication related to shareholder documentation and stock exchange notification.
2022-07-14 English
Loss of share certificate
Regulatory Filings Classification · 95% confidence The document is an official communication from a company to stock exchanges regarding a request for issuance of duplicate share certificates due to loss of original certificates. It references SEBI regulations and procedural requirements for issuing duplicate certificates. The content is about a specific shareholder's share certificate issue and the company's notification to exchanges. There are no financial statements, earnings data, or management discussion. The document is a regulatory announcement related to share certificate loss and replacement, not a financial report or meeting material. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2022-07-12 English
Postal Ballot
Regulatory Filings
2022-07-07 English
Loss of share certificate
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding a shareholder's request for issuance of a duplicate share certificate due to loss of the original. It references SEBI regulations and procedural requirements for issuing a Letter of Confirmation in lieu of a duplicate share certificate. The content is an official notification about a share certificate issue, not a financial report, earnings release, or management discussion. It does not contain financial data or analysis, nor does it announce voting results or capital changes. This fits best under Regulatory Filings (RNS), which covers miscellaneous regulatory announcements and compliance-related disclosures that do not fit other categories.
2022-06-30 English
Loss of share certificate
Regulatory Filings Classification · 95% confidence The document is an official communication from a company to stock exchanges regarding a shareholder's request for issuance of a duplicate share certificate due to loss of the original. It references SEBI regulations and a procedural update about issuing a Letter of Confirmation in lieu of a duplicate share certificate. The content is about a specific shareholder's share certificate issue and the company's notification to exchanges. There are no financial statements, earnings data, or management discussion. The document is an announcement related to share certificates and shareholder records, not a financial report or meeting material. It fits best under Regulatory Filings (RNS) as it is a compliance-related announcement to stock exchanges about share certificate loss and replacement.
2022-06-28 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release announcing encouraging top-line results from a Phase II/III clinical trial of a COVID-19 vaccine by Biolexis and Akston Biosciences. It contains no detailed financial data, regulatory filings, or formal report structures such as annual or quarterly reports. It is a public announcement of clinical trial results and business updates related to vaccine development and commercialization. The document is not a financial report, regulatory filing, or management discussion. It fits best as a general regulatory announcement or miscellaneous corporate communication. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2022-06-24 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.